Abstract
The present study explores characteristics of successful substance abuse treatment completion of pregnant women through an analysis of retrospective outcomes data. Women without prior treatment admissions, aged 18–44, and not in methadone maintenance therapy were included (N = 678,782). Chi-square tests analyzed significant differences; logistic regression provided predictive probabilities; odds ratios (OR) and risk differences with 95 % confidence intervals represent the effect sizes and clinically meaningful differences. Pregnant women were less likely to successfully complete treatment than non-pregnant women (χ 2 = 321.33, df = 1, p < 0.0001), though the difference was not clinically meaningful (risk difference = 4.75, 95 % confidence interval (CI) = 4.23–5.26). Aside from criminal justice agencies, “other community agencies” refer the greatest percentage of pregnant women to treatment (risk difference = 6.37, 95 % CI = 5.89–6.84). Pregnant women successfully complete treatment more than non-pregnant women in only non-intensive outpatient settings (χ 2 = 10,182.48, df = 7, p < 0.0001). Further attention to referral source and treatment setting for pregnant women may improve successful treatment completion by targeting needs of pregnant women. Referring to non-intensive outpatient and residential hospital treatment settings may help to ameliorate prenatal substance abuse treatment contingent on the primary problem substance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ackerman JP, Riggins T, Black MM (2010) A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 125:554–565. doi:10.1542/peds. 2009-0637
Albrecht J, Lindsay B, Terplan M (2011) Effect of waiting time on substance abuse treatment completion in pregnant women. J Subst Abus Treat 41:71–77. doi:10.1016/j.jsat.2011.01.015
Arndt S, Acion L, White K (2013) How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend 132:547–555
Ashley OS, Marsden ME, Brady TM (2003) Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 29:19–53. doi:10.1081/ADA-120018838
Bluthenthal RN, Jacobson JO, Robinson PL (2007) Are racial disparities in alcohol treatment completion associated with racial differences in treatment modality entry? Comparison of outpatient treatment and residential treatment in Los Angeles County, 1998 to 2000. Alcohol Clin Exp Res 31:1920–1926. doi:10.1111/j.1530-0277.2007.00515.x
Chasnoff IJ, Neuman K, Thornton C, Callaghan MA (2001) Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol 184:752–758. doi:10.1067/mob.2001.109939
Evans E, Li L, Hser Y-I (2009) Client and program factors associated with dropout from court mandated drug treatment. Eval Program Plann 32:204–212. doi:10.1016/j.evalprogplan.2008.12.003
Fischer G, Bitschnau M, Peternell A et al (1999) Pregnancy and substance abuse. Arch Womens Ment Health 2:57–65. doi:10.1007/s007370050037
Garnick DW, Lee MT, Horgan CM, Acevedo A (2009) Adapting Washington Circle performance measures for public sector substance abuse treatment systems. J Subst Abus Treat 36:265–277. doi:10.1016/j.jsat.2008.06.008
Grella CE (1999) Women in residential drug treatment: differences by program type and pregnancy. J Health Care Poor Underserved 10:216–229. doi:10.1353/hpu.2010.0174
Guerrero EG, Marsh JC, Duan L et al (2013) Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res 48:1450–1467. doi:10.1111/1475-6773.12031
Howell EM, Heiser N, Harrington M (1999) A review of recent findings on substance abuse treatment for pregnant women. J Subst Abus Treat 16:195–219
Hser Y-I, Evans E, Huang D, Messina N (2011) Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs. J Subst Abus Treat 41:115–123. doi:10.1016/j.jsat.2011.02.004
Kennedy C, Finkelstein N, Hutchins E, Mahoney J (2004) Improving screening for alcohol use during pregnancy: the Massachusetts ASAP program. Matern Child Health J 8:137–147
Kuczkowski KM (2007) The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 19:578–585. doi:10.1097/GCO.0b013e3282f1bf17
Lindsay B, Albrecht J, Terplan M (2011) Against professional advice: treatment attrition among pregnant methamphetamine users. Subst Abuse Rehabil 2:189–195. doi:10.2147/SAR.S25083
Longinaker N, Terplan M (2014) Effect of criminal justice mandate on drug treatment completion in women. Am J Drug Alcohol Abuse 40:192–199. doi:10.3109/00952990.2013.865033
Lundsberg LS, Bracken B, Safiylas AF (1997) Low-to-moderate gestational alcohol use and intrauterine growth retardation, low birthweight, and preterm delivery. Ann Epidemiol 7:498–508
McCabe JE, Arndt S (2012) Demographic and substance abuse trends among pregnant and non-pregnant women: eleven years of treatment admission data. Matern Child Health J 16:1696–1702. doi:10.1007/s10995-011-0872-z
Ondersma SJ, Simpson SM, Brestan EV, Ward M (2000) Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat 5:93–108. doi:10.1177/1077559500005002002
Schempf AH (2007) Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv 62:749–757. doi:10.1097/01.ogx.0000286562.31774.76
The American College of Obstetricians and Gynecologists (2008) At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice ACOG committee opinion no. 422. Obstet Gynecol 112:1449–1460
Tzilos G, Hess L, Kao JC-W, Zlotnick C (2013) Characteristics of perinatal women seeking treatment for marijuana abuse in a community-based clinic. Arch Womens Ment Health 16:333–337. doi:10.1007/s00737-013-0358-7
United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Office of Applied Sciences (2009) Treatment Episode Data Set-Discharges (TEDS-D)—concatenated, 2006 to 2008
United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Office of Applied Sciences (2010) Treatment Episode Data Set-Discharges (TEDS-D)—2009
Yonkers KA, Gotman N, Kershaw T et al (2010) Screening for prenatal substance use. Obstet Gynecol 116:827–833
Zarkin GA, Dunlap LJ, Bray JW, Wechsberg WM (2002) The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment. J Subst Abus Treat 23:261–271
Ethical standards
This study was exempted by the University of Iowa Institutional Review Board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This research was performed with preexisting de-identified data made publicly available through the US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Office of Applied Studies.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahker, E., McCabe, J.E. & Arndt, S. Differences in successful treatment completion among pregnant and non-pregnant American women. Arch Womens Ment Health 19, 79–86 (2016). https://doi.org/10.1007/s00737-015-0520-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-015-0520-5